We combine rigorous research methodologies with extensive healthcare knowledge.
We conduct rapid cycle projects and provide you actionable insights quickly and efficiently.
HITLAB Research in Review
HITLAB’s Research practice has deep expertise in innovation and the design and implementation of new digital health technologies. Utilizing a variety of offerings from rapid cycle verification studies to implementation pilots, HITLAB Research can help quickly assess the potential outcome efficacy and economic value of new technologies.
The team combines rigorous research methodologies with extensive healthcare knowledge and business expertise to provide stakeholders actionable insights quickly and efficiently.
Sara is a healthcare delivery researcher and digital health strategist dedicated to improving the healthcare experience for all.
A social scientist by training, Sara applies her expertise in qualitative research methods and user-centered design to incorporate the needs and priorities of clinicians, patients and their families into the development of innovative, useful, and useable health informatics tools. Previously on the faculty at NYU Langone’s Center for Healthcare Innovation and Delivery Science, Sara currently directs the research service line at HITLAB (Healthcare Information Technology Lab) and serves on the Board of HITLAB’s Women’s HealthTech Initiative.
Meet Sara Chokshi
Director, HITLAB Research
Spotlight on Collaborators
“I have collaborated with HITLAB and the team on a number of different projects over the past decade. During this time, I have come to value the vision of digital health, innovation and its potential for promoting health and treating illness.”
—Jason Lazar, Vice Dean of Education
HITLAB is collaborating with the Cardiology Department of SUNY Downstate Health Sciences University’s: Dr. Jason Lazar and Dr. Gulzhan Tologonova, Medical Graduate on two current cardiology-focused digital health verification studies.
SUNY downstate is the only college of medicine in Brooklyn and provides care for underserved populations. “It is part of our mission to ensure that digital health solutions serve to create equity and reduce disparities in care,” said Dr. Lazar, the Vice Dean of Education at SUNY Downstate College of Medicine.
The AccurKardia study is a collaboration between HITLAB, the SUNY Downstate team and cardiology-focused start up Accurkardia, headed by CEO and Co-founder Juan Jiminez. The study is aimed at examining the accuracy and feasibility of using the company’s clinical-grade, device agnostic, API electrocardiology analytics capabilities with data from a smart-watch. Using deep learning models, they are evaluating the potential and accuracy of real time QT interval measurement from a smart watch relative to traditional EKGs. The work is ongoing but preliminary findings indicate AccurKardia’s solution holds great promise for remote measurement of important cardiologic health indicators such as the QT interval.
The team is planning a follow up collaboration expanding the study to evaluate the use of the technology with a wider patient population.
HILTAB’s research conducted in collaboration with Brightside and Yalini Senathirajah, PhD was published in Cureus Journal of Medical Science. The article “The comparative evaluation of measurement-based psychiatric care delivered via specialized telemental health platform vs. treatment as usual: A retrospective analysis” examines the effectiveness of a telemental health platform compared to treatment as usual (TAU) in significantly reducing symptoms of depression in adults.
The telemental health platform approach is predicated on the hypothesis that algorithmic clinical decision support, plus frictionless communication between patient and prescriber, along with more frequent measurement-based assessments and medication adjustment, yields better outcomes for patients. While Brightside offers psychiatric services alone as well as in combination with therapy, the focus of this study is on the platform’s core offering of psychiatric care and medication delivery.
Congratulations to the entire Brightside team as well as to Sara Chokshi, DrPH, Vandana Yadav and the entire HITLAB research practice!.
Sara Chokshi and Kat Marriott will be presenting at the upcoming American Telehealth Association Conference (ATA2022 Annual Conference and Expo) in Boston May 1st. The poster to be presented is titled “The Acceptability and Implementation of an Online Cognitive Behavior Therapy Platform,” and features preliminary findings from a recent collaboration with OPTT.
National Women’s Health Week is May 8-May 14th. As such Sara Chokshi will be presenting on a panel with other Female health leaders. She will be sharing her insights on “Gender Inequality” in women’s health. The event is May 11th from 1pm-2pm.
Interested in hearing how HITLAB research can work with you and your organization?
About HITLAB Research
We operate at the intersection of digital health and innovation to help entrepreneurs from concept through commercial launch. We combine rigorous research methodologies with extensive healthcare knowledge and business expertise to conduct rapid cycle projects and provide you actionable insights quickly and efficiently.
NYCEDC launched the Digital Health Breakthrough Network in 2016 as part of its broader efforts to facilitate growth in New York City’s healthcare and life sciences sectors. Now, HITLAB operates the program independently and continues to provide prototype testing services to the digital health ecosystem.